Based On The Harvard Analysis Framework Of Financial Statements Of HPGC

The pharmaceutical industry is the pillar industry of the national economy,its relationship with the people’s livelihood,relating to health,social stability and order as well as the healthy development of the people’s economy,while high-tech industries as the pharmaceutical industry is China’s "Twelfth Five-Year Plan" focus to support the industry.Harbin Pharmaceutical Group Co., Ltd.(hereinafter all referred to as:Shaya shares)as the first listed company in the domestic pharmaceutical industry,because of its high market position and competitive potential, has been the attention of investors,therefore,Harbin Pharmaceutical shares financial reporting and business analysis of investment decisions related to the management of economic activities of participants have a very important reference value.Harvard University Palepu、Healy and Bernard in "the use of corporate financial statements analysis and assessment," a book made a financial strategy analysis and financial statement analysis in one of the "Harvard Analytic Framework." This paper aims to use the Harvard Analytic Framework, the system master this important financial analysis tools,Harbin Pharmaceutical shares of financial statements for qualitative analysis and quantitative analysis, the aim is to master the system, while the financial analysis tools for business managers to make decision-making and other stake holders to provide effective support.This paper is divided into seven parts: the first part introduces the research background, research status at home and abroad, research ideas and research innovation.The second part introduces the basic theory framework of financial statements analysis of Harvard, firstly analyzes the basic theory and the limitations of the traditional analysis of financial statements, then introduces the basic theory of the Harvard Analysis framework.The third part is the strategic analysis of the target enterprise Harbin Pharmaceutical shares, mainly analyzes the development status of the industry, Harbin Pharmaceutical shares with Potter’s five forces model analysis the profitability of pharmaceutical industry and the introduction of SWOT analysis method to analyze the specific strategy to Harbin Pharmaceutical shares.The fourth part is the analysis of Harbin Pharmaceutical shares of accounting, is mainly the analysis of Harbin Pharmaceutical shares using appropriate accounting policies and accounting estimates, the accounting analysis confirmed the reliability of Harbin Pharmaceutical shares of the quality of accounting information.The fifth part is based on the analysis of accounting on the Harbin Pharmaceutical shares of financial analysis, this part carries on the financial analysis is mainly the use of ratio analysis, trend analysis method to conduct in-depth analysis of the enterprise’s financial statements, the evaluation of enterprise’s solvency, profitability, operation ability and cash flow condition, and selected two companies in the same industry as compared with comparative analysis, to find out the defects in the management of the company and the insufficiency.The sixth part is the analysis of the strategic analysis, accounting analysis and financial prospects based on the analysis, this part forecasts the future development trend of Harbin Pharmaceutical shares, and provide support for the decision-making of enterprises. The last part of the thesis is summarized.